Tanya Wilhite, MBA
About Tanya Wilhite, MBA
Company
Tanya Wilhite currently works at Bristol Myers Squibb. She holds the position of Associate Director, Regional Marketing, US Immunology. Previously, she worked in other significant roles at the company, including Associate Director of Regional Marketing for US Oncology and Marketing Preceptor/Senior Territory Business Manager.
Title
Currently, Tanya Wilhite holds the title of Associate Director, Regional Marketing, US Immunology at Bristol Myers Squibb. She has held this position in Indiana, United States. Throughout her career at Bristol Myers Squibb, she has held several roles that emphasized her expertise in strategic marketing.
Education and Expertise
Tanya Wilhite achieved her Master of Business Administration (MBA) in Marketing from Indiana University's Kelley School of Business. She also completed her undergraduate education studying Pre-Medicine/Pre-Medical Studies at Northwestern University and earning a Bachelor of Science (BS) at Purdue University. Her academic background solidifies her extensive knowledge in strategic marketing and sales across therapeutic areas such as oncology, hematology, dermatology, rheumatology, and rare diseases.
Background
Tanya Wilhite has a diverse professional background, having served in various roles within the pharmaceutical industry. She worked as a Sr. Immunology Specialist at AbbVie for nine years and as a National Training Manager and Neurology Sales Specialist at Abbott. Her career also includes experience as a Cardiovascular Sales Specialist at Sanofi and Marketing Manager at Personel Management Incorporated.
Achievements
Tanya Wilhite's career is marked by her extensive experience and leadership within the pharmaceutical industry. She has demonstrated stellar coaching skills and has led professional settings effectively. In her role at Abbott as National Training Manager, she honed her background in training professionals. Her leadership qualities have contributed significantly to her roles at major companies, including Bristol Myers Squibb and AbbVie.